Granuflo Complications Lead to Lawsuits Against Fresenius Medical Care
The company of Fresenius Medical Care is facing product liability lawsuits in relation to its GranuFlo dialysis treatment. The number of lawsuits filed in court is expected to rise in the coming...
View ArticleTestosterone May Increase Risk for Prostate Cancer
Testosterone is a naturally occurring hormone that is higher in a man’s body than a woman’s. It plays an essential role in sex drive, reproductive ability, and energy levels. Health professionals have...
View ArticleJudge Agrees With Jurors but Reduces Actos Award Against Eli Lilly and Takeda...
November 24, 2014—A federal judge reduced the amount of money drug manufacturers Eli Lilly and Co. and its former partner Takeda will need to pay in punitive damages involving its diabetes drug Actos....
View ArticleTakeda Ordered to Pay $155,000 in Actos Lawsuit for Destroying Evidence
December 3, 2014—Takeda Pharmaceuticals Co. was recently ordered to pay a $155,000 fine as a result of its destruction of documents related to its diabetes drug Actos. The jury believed the company...
View ArticlePlaintiffs in Xarelto Case Requesting Consolidation in Illinois Court
December 16, 2014—There is an effort underway to consolidate lawsuits against drug manufacturers Bayer AG and Johnson & Johnson in relation to the companies’ blood-thinning drug Xarelto. The move...
View ArticleStudy Finds First Time Testosterone Users at Higher Risk of Heart Attack
January 22, 2015 – The latest in a collection of medical studies shows increasing evidence that first-time testosterone medication users face an increased risk for heart attack based on their use of...
View ArticleFDA Issues New Label Requirements for Testosterone Therapy Medications
March 3, 2015 – The FDA recently issued a new requirement for testosterone manufacturers to include on all product labels the approved uses of the medication, as well as the cardiovascular risks. These...
View ArticleThousands of Men Suing Over Testosterone Use Face Battles Ahead
The number of men who have filed lawsuits after injuries and health problems sustained from using testosterone supplements continues to increase. More than 1300 additional men recently joined an...
View ArticleCommon Reflux Drug Linked to Heart Attack
Recent results of tow studies have confirmed that patients who use proton pump inhibitors (PPIs) for reflux, may have up to a 21 percent increased risk of heart attacks when compared to those who don’t...
View ArticleMRI Drugs: Are They Leaving Dangerous Residue Behind in the Brain?
Usually, getting an MRI done is described as a necessary based on a patient’s condition at the time. When further research is needed to determine the existence or extent of a problem, an MRI is one of...
View ArticleBenicar Linked to Gastrointestinal Problems
The number of Benicar lawsuits continues to grow, as nearly 100 additional patients came forward in August to file a suit against Daiichi Sankyo, Inc., Daiichi Sankyo Co. Ltd., and Forest Laboratories,...
View ArticleDoes Testosterone Replacement Therapy Really Work?
Testosterone therapy is used to boost testosterone in men with decreasing levels, but there is now evidence the prescription products do little to improve ejaculatory function, as claimed. There are...
View ArticleInvokana Update 2016: FDA Safety Announcements & Lawsuit Update
The U.S. Food and Drug Administration has issued a third set of warnings about serious adverse events that may occur after taking the antidiabetic medication, Invokana. The first warning had been...
View ArticleProton Pump Inhibitors (PPIs) Linked to Kidney Failure & Kidney Disease
A recent study has shown that the use of proton-pump inhibitor medications may be associated with an increase in the risk of chronic kidney disease. The results were published in the February 2016...
View ArticleNexium Lawsuit Filed for Acute Interstitial Nephritis (AIN)
Nexium is a drug used to treat heartburn and acid reflux disease, and is one of the most used medications in the United States. Recently, allegations have arisen accusing Nexium of causing kidney...
View ArticleKetoacidosis Problems Known on Johnson & Johnson’s Janssen Pharmaceuticals...
A recent product liability lawsuit against Invokana manufacturer Johnson & Johnson’s Janssen Pharmaceuticals alleges the company knew of the risks associated with the drug, but minimized the...
View ArticleRecent FDA Action May Increase the Number of Invokana Injuries
Just three years after its approval, the Type 2 diabetes medication, Invokana (canagliflozin), multiple warnings and safety alerts have already been issued due to serious concerns about the potential...
View ArticleUsers of Proton Pump Inhibitors (PPIs) May Develop Chronic Kidney Disease...
A new study shows that users of proton-pump inhibitor medications (PPIs), while at a higher risk for chronic kidney damage, may not show immediate symptoms – letting their silent, potentially...
View ArticleInvokana Update 2017: FDA Steps Up Warnings About Invokana
In June 2016, the FDA strengthened its prior warnings about the diabetes medication Invokana, advising in a safety announcement that patients who had taken Invokana should seek medical attention...
View Article2017 Update: Testosterone Replacement Therapy
Testosterone replacement therapy may not deliver the benefits it advertises and potentially carries risks for cardiovascular health, according to new research published in February 2017. Testosterone...
View Article
More Pages to Explore .....